Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference
STAMFORD, Conn., April 10, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a…
0,300€
3,45%
Echtzeit-Aktienkurs Cara Therapeutics
Bid:
Ask:
Nachrichten zur Cara Therapeutics Aktie
Insiderhandel: Chief Scientific Off,SVP-R&D verkauft Aktien von Cara Therapeutic im Wert von 13.419$
Menzaghi, Frederique Ph.d. - Vorstand - Tag der Transaktion: 2023-04-04...…
Insiderhandel: Secy; Chief Compliance & G.C. verkauft Aktien von Cara Therapeutic im Wert von 12.182$
Terrillion, Scott - Vorstand - Tag der Transaktion: 2023-04-04...…
Expert Ratings for Cara Therapeutics
Latest Ratings for CARA
DateFirmActionFromTo Mar 2022JP MorganUpgradesNeutralOverweight Aug 2021HC Wainwright & Co.MaintainsBuy Aug 2021JP MorganInitiates Coverage OnNeutral
…
Form 8-K Cara Therapeutics, Inc. For: Mar 23
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report
STAMFORD, Conn., March 14, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a…
Form 8-K Cara Therapeutics, Inc. For: Mar 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Cara Therapeutics downgraded to underperform from neutral at BofA Securities
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Cara Therapeutics Shares Tumble Premarket After 4Q Report >CARA
Cara Therapeutics Shares Tumble Premarket After 4Q Report >CARA...…
Cara Therapeutics (CARA) Reports Q4 Loss, Misses Revenue Estimates
Cara (CARA) delivered earnings and revenue surprises of -69.70% and 76.75%, respectively, for the quarter ended December 2022. Do the…
Cara Therapeutics plummets 29% on quarterly misses; enough cash to operate to H1 2024
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 10-K Cara Therapeutics, Inc. For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
– 4Q22 total revenue was $3.3 million including collaborative revenue of $1.1 million from the Companys share of profit of…
Will Cara Therapeutics (CARA) Report Negative Earnings Next Week? What You Should Know
Cara (CARA) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Insiderhandel: Chief Medical Officer verkauft Aktien von Cara Therapeutic im Wert von 23.103$
Goncalves, Joana - Vorstand - Tag der Transaktion: 2023-02-16...…
Insiderhandel: President and CEO verkauft Aktien von Cara Therapeutic im Wert von 49.454$
Posner, Christopher - Vorstand - Tag der Transaktion: 2023-02-02...…
Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference
STAMFORD, Conn., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a…
Bain Capital Life Sciences Discloses Position in CARA / Cara Therapeutics
A Bain Capital fund has disclosed ownership of 5% of Cara Therapeutics....…
Insiderhandel: President and CEO verkauft Aktien von Cara Therapeutic im Wert von 161.051$
Posner, Christopher - Vorstand - Tag der Transaktion: 2022-11-16...…
Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates
Cara (CARA) delivered earnings and revenue surprises of -2.38% and 28.91%, respectively, for the quarter ended September 2022. Do the…
Form 8-K Cara Therapeutics, Inc. For: Nov 07
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Cara Therapeutics Reports Third Quarter 2022 Financial Results
– Net revenue was $16.2M for 3Q22 including profit-sharing revenue of $7.4M from KORSUVA® (difelikefalin) injection –...…
Cara Therapeutics Q3 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Cara Therapeutics (CARA) Might Surprise This Earnings Season
Cara Therapeutics (CARA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings…
Cara Therapeutics to Present at Upcoming Investor Conferences
STAMFORD, Conn., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a…
Cara Therapeutics (CARA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Cara (CARA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
Cara Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022
STAMFORD, Conn., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a…
SWK Holdings unit receives $5M payment from Cara Therapeutics
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Global Legal Cannabis Market Report 2022-2030 Featuring Gw Pharmaceuticals, Aurora, Aphria, Cronos, Tilray, Sundial Growers, Insys Therapeutics, Scotts Co, Vivo Cannabis, & Cara Therapeutics
DUBLIN, Oct. 6, 2022 /PRNewswire/ -- The "Legal Cannabis Market Size, Share & Trends Analysis Report by Source (Marijuana, Hemp),…